Aggregation: Why pharmaceutical companies to consider aggregation as the next step?

 

Aggregation is a new opportunity in Supply Chain drug Traceability

 

Pharmaceutical companies will achieve meaningful cost-savings by using traceability and aggregation solutions. A large part of these changes come from an upgrade in the production process. Nowadays, many pharmaceuticals see this full solution as a key advantage.

 

 

Insights

More Related Articles

Sustainability Report 2025

Global Pharmaceutical Serialization Regulations in 2026 Tracker

GTIN – the power of standardization in the pharma industry

Italy Medicines Traceability Compliance: Preparing for the NMVO Italia Enforcement Phase